How we generate value

Rejuvenate Biomed, how we generate value image

Building an exciting pipeline

Rejuvenate Biomed pipeline


Rejuvenate Biomed One Pager


Positive results Phase 1b trial in sarcopenia

Primary and secondary endpoints have been met in this placebo-controlled study in disuse-induced muscle atrophy. RJx-01 was safe and well tolerated and the innovative formulation confirmed excellent pharmacokinetics.

Acknowledgements and investors